Related by context. Frequent words. (Click for all words.) 66 Phase 2a clinical 66 phase IIb 65 phase IIa 65 Phase 2a trial 64 Phase 1a 64 Phase IIa clinical 64 Phase IIa trial 64 Phase 2b clinical 63 phase 2a 63 Pivotal Phase III 63 Phase 1b clinical 62 Phase Ib 62 Phase 1b 62 tanespimycin 61 Phase 2b 61 Amrubicin 61 Phase 1b trial 61 Phase IIb clinical 61 PRECiSE 60 Phase 2b study 60 dose escalation trial 60 Phase IIa 60 placebo controlled clinical 60 relapsed refractory multiple myeloma 60 Phase Ia 60 aclidinium 60 randomized Phase III 60 Pivotal Phase 60 Phase 2b trial 59 Cloretazine R VNP#M 59 Phase III 59 pivotal Phase III 59 thymalfasin 59 CR# vcMMAE 59 double blinded placebo 58 Phase 2a 58 tesmilifene 58 TG# [001] 58 dose cohorts 58 EORTC 58 multicenter clinical 58 Azedra 58 Phenoptin 58 BAY #-# 58 Pirfenidone 58 BCX# 58 Phase IIb 57 axitinib 57 Clinical Trial Results 57 Pivotal Trial 57 Phase III clinical 57 CoFactor 57 sapacitabine 57 abiraterone acetate 57 Phase III pivotal 57 rNAPc2 56 NSABP 56 confirmatory Phase 3 56 HuMax CD# 56 Immunogenicity 56 AVN# [001] 56 Phase III Trial 56 PA# [002] 56 secondary efficacy endpoints 56 Phase IIa clinical trials 56 glufosfamide 56 Pharmacokinetic 56 INCB# [002] 56 Phase III trials 56 ISIS # 56 multiple ascending dose 56 placebo controlled randomized 56 ofatumumab 56 Phase II 56 VEGF Trap 55 AMR# 55 SCH # 55 KNS # 55 registrational 55 Phase IIb trial 55 HER2 positive metastatic breast 55 PXD# 55 Telaprevir 55 IIa clinical trial 55 RDEA# 55 eltrombopag 55 Laquinimod 55 BLA submission 55 Asentar 54 integrase inhibitor 54 ASA# 54 TASQ 54 Phase III randomized 54 PS# [001] 54 diabetic neuropathic pain 54 CRx 54 pharmacokinetic studies 54 active comparator 54 IMGN# 54 ELND# 54 Nasdaq VRTX